CX
Cemex SAB de CV
$10.72
▲ 0.6%Updated Today 11:13 AM ET
CX at a glance — five pillars scored 0–100 from real filed financials.
Overall: Weak · 37/100. A wider, greener shape means more pillars look healthy. Dividends scores 0 when a company pays none — that is a choice, not a flaw.
▲ Up 69.8% over the last 12 months
Market Cap
$19.65B
P/E
36.23x
Forward P/E (est.)
51.76x
ROE
3.4%
Revenue Growth
3.3%
EPS Growth
-72.7%
Profit Margin
2.7%
FCF Yield
15.9%
Debt / Equity
0.51x
ROIC
8.0%
Interest Coverage
—
Current Ratio
0.82x
Dividend Yield
—
Implied Growth (rev. DCF)
4.3%
Rating Score
37/100
Cemex SAB de CV (CX) is a large-cap company in the Construction industry, part of the Industrials sector of the S&P 500, with a market value around $19.65B.
In its latest reported year it generated about $16.20B in revenue and $939.00M in net profit.
Our model rates CX Weak (37/100) on growth, profitability, financial health, and valuation. The summary below is built from its filed financials and current ratios and refreshes automatically.
Evidence of durable competitive advantage in the filed financials (8 years of history).
Some durable-advantage evidence, but not across the board — dig into which ingredient is weak and whether it's cyclical or structural.
32.6% average over the last 3 years
±1.4 pts around 33.1% across 8 years
grew in 4 of the last 7 year-over-year periods
positive in 8 of 8 years
8.0% latest fiscal year
A moat can't be proven by numbers alone — this scores the evidence a durable advantage leaves behind (pricing power, consistency, returns on capital), computed the same way for every stock. Pair it with the business overview before concluding anything.
Technical analysis reads price and volume to judge momentum and timing. It complements the fundamentals above — it does not replace them. Here is what CX's chart says today, with each tool explained.
Trend — moving averages. A moving average is the average closing price over a window, which smooths out daily noise. CX trades near $10.72, below its 50-day average ($12.61) and 200-day average ($11.44). Price below both averages is a downtrend — momentum is against buyers for now.
Momentum — RSI. The Relative Strength Index runs 0–100 and measures how strong recent gains are versus losses. Above 70 is "overbought", below 30 "oversold". At 36 it is in neutral territory — neither stretched nor washed out.
MACD. MACD compares two moving averages to flag shifts in momentum. Its histogram is currently negative — short-term momentum is fading.
Volatility — ATR. Average True Range is the typical daily move. CX's is $0.36 (~3.4% of price), so swings of about that size each day are normal — handy for setting a stop that isn't too tight.
Support & resistance. Over the last month CX found buyers near $11.65 (support) and sellers near $13.40 (resistance); its 52-week range is $7.12–$13.67. A decisive break beyond either edge often marks the next move.
Volume. The latest session traded 0.6× the 20-day average — lighter than usual, so the move carries less conviction. Rising volume on up-days suggests real buying; on down-days, real selling.
Educational information to help you read a chart — not a recommendation or a forecast. It updates daily as the price and indicators change.
4Y CAGR
6.3%
Revenue moved from $12.93B in 2017 to $16.20B in 2024, a 3.3% compound annual growth rate. The most recent year was roughly flat (3.3%) year over year. Slower, mature growth is common for established businesses.
Gross Margin
33.6%
Operating Margin
11.2%
Net Margin
5.8%
ROE
3.4%
Cemex SAB de CV keeps about 2.7% of each sales dollar as net profit, with a 33.6% gross margin and 11.2% operating margin. Return on equity is 3.4% and return on invested capital about 8.0%. Thin margins leave less cushion if costs rise.
Total Debt
$5.34B
Net Debt
$4.48B
Net Debt / EBITDA
2.46x
Debt / Equity
0.51x
Leverage: debt-to-equity is 0.5x, with a current ratio of 0.8x. That is a moderate, manageable debt load for most businesses. It carries roughly $5.34B of total debt against $864.00M of cash.
Operating CF
$1.89B
Free Cash Flow
$894.00M
FCF Margin
5.5%
In the latest year Cemex SAB de CV produced about $1.89B of operating cash flow and $894.00M of free cash flow after capital spending. That is a free-cash-flow yield of about 15.9% on today's price. Strong cash generation funds dividends, buybacks, and reinvestment.
Can the payout survive a bad year? Scored from filed cash flow, earnings coverage, and the raise/cut record.
The dividend is being paid, but coverage or consistency is thinner than an income investor should rely on without a closer look.
Total paid (latest FY)
$90.00M
History on record
2 years
dividend uses 10% of free cash flow
10% of net income paid out
no current raise streak
payout was cut at least once in the last 2 years
Coverage uses the latest fiscal year as filed with the SEC; the streak counts total dollars paid (per-share figures can carry split artifacts). Educational information, not income advice.
P/E
36.23x
P/S
1.16x
P/B
1.19x
EV / EBITDA
7.85x
CX trades at 36.2x trailing earnings (about 51.8x on estimated forward earnings), 1.2x sales, and 1.2x book value. Reverse-engineering today's price implies the market expects roughly 4.3% long-term free-cash-flow growth. That is a premium multiple that needs growth to justify it.
A two-stage discounted cash flow on real SEC-filed free cash flow — the intrinsic-value anchor professional analysts triangulate from.
DCF fair value / share
$1.02
Current price
$10.72
Starting FCF (latest 10-K)
$894.00M
Growth, years 1–5
3.3%
Fade to terminal, years 6–10
2.5%
Discount rate
9.0%
Cash flows grow at the stage-1 rate (trailing revenue growth, capped at 20%) for five years, fade to 2.5% by year 10, and continue at that rate forever (Gordon terminal value), all discounted at 9.0%. Small changes in assumptions move the result a lot — treat this as one reference point, not a target price. Educational only, not investment advice.
Where CX sits versus its Industrials sector peers in the S&P 500.
Bands show the middle half (25th–75th percentile) of the 144 Industrials companies in the S&P 500 — the peer-relative anchor professional comps analysis uses. Context only — not investment advice.
How CX stacks up against its Industrials peers — valuation, profitability, and growth versus the sector median.
In the Industrials sector (273 S&P 500 companies), CX ranks #121 of 273 by our overall rating. It trades at a premium versus the sector on earnings (36.2x P/E vs. 31.4x median) with a lower return on equity (3.4% vs. 18.1%) and slower revenue growth (3.3% vs. 6.0%).
P/E vs sector
36.2x
median 31.4x
ROE vs sector
3.4%
median 18.1%
Growth vs sector
3.3%
median 6.0%
Sector rank
#121
of 273 by rating
Valuation vs. quality map
The sweet spot is upper-left: more profitable (higher ROE) for a lower P/E. Dashed lines mark the sector median.
Peers are the closest Industrials companies by sub-industry and size. Sector median is across all 273 S&P 500 names in the sector. Educational, not a recommendation.
Project revenue → earnings → price. Edit the assumptions to build your own case.
2030 price target (Base Case)
$0.00 – $0.00
vs. $10.72 today · expected CAGR 5% – 16%
| Metric | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| Revenue | $16.69B | $17.19B | $17.70B | $18.23B | $18.78B |
| Net income | $1.00B | $1.03B | $1.06B | $1.09B | $1.13B |
| EPS | $0.55 | $0.56 | $0.58 | $0.60 | $0.61 |
| Share price (low) | $12.02 | $12.38 | $12.75 | $13.13 | $13.53 |
| Share price (high) | $19.67 | $20.26 | $20.86 | $21.49 | $22.14 |
| CAGR (low–high) | 12% / 83% | 7% / 37% | 6% / 25% | 5% / 19% | 5% / 16% |
Educational model on sample fundamentals — not a forecast or investment advice. Outputs are only as good as your assumptions.
The case for CX:
- Healthy free-cash-flow yield (~15.9%) funds buybacks and dividends.
- As an established S&P 500 member in Industrials, it brings scale and a long operating history.
The case against CX:
- Thin net margins (2.7%) leave little room for error.
- Our model's overall read is Weak (37/100).
Valuation risk — at 36.2x earnings, disappointing results could compress the multiple.
Margin risk — thin profitability (2.7%) is vulnerable to cost or pricing pressure.
Market risk — sector rotation, the economic cycle, and broad sentiment move the stock regardless of fundamentals.
On balance, the fundamentals screen weakly: Cemex SAB de CV is a large-cap industrials business growing at a mature pace, with modest profitability, and a sound balance sheet. It trades at 36.2x earnings, which our model scores Weak (37/100). Weigh this against your own goals and time horizon — this is educational information, not a recommendation.
Analyst Ratings
What 15 Wall Street analysts covering CX recommend (August 2026). Consensus is a useful sanity check — not a substitute for your own homework.
Analysts have turned more positive over the last three months (+7 pts of buy ratings).
Latest SEC Filings
CX's most recent filings, straight from SEC EDGAR. Annual and quarterly reports are the deep dives; 8-Ks flag material events the moment they happen.
CX — frequently asked questions
Is CX a good stock to buy?
We don't give buy or sell advice. Our model rates Cemex SAB de CV Weak (37/100) based on its growth, profitability, financial health, and valuation — use that as a research starting point and make your own decision.
What is CX's rating on The Stocks School?
Cemex SAB de CV currently scores 37/100 (Weak) on our transparent model, which weighs real fundamentals: growth, margins, returns on capital, balance-sheet strength, and valuation.
How our ratings work →Where does CX's data come from?
Live price data plus real fundamentals and 5-year financials pulled directly from Cemex SAB de CV's SEC filings — refreshed automatically, not hand-entered.
How is the 5-year projection for CX calculated?
It's a scenario model: it grows revenue at an assumed rate, applies a profit margin and a valuation multiple, and shows the resulting share-price range. The assumptions are yours to change — it's a tool for thinking, not a prediction.
Is this CX analysis financial advice?
No. Everything on this page is educational research, not financial advice or a recommendation to buy or sell CX. Always do your own research and consider a licensed professional.
Data notice. Fundamentals and financial statements are sourced from company filings (SEC EDGAR) and market-data providers; prices and market caps refresh on trading days and may be delayed. Ratings, projections, technical signals, and written summaries are model- or rule-generated for education and may simplify or lag the latest filings.
Not advice. Nothing on this page is investment advice or a recommendation to buy, hold, or sell any security. Do your own research and consult a licensed financial professional before investing.